Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Leicester researchers discover a potential molecular defence against Huntington's disease

26.08.2013
University of Leicester experts discover glutathione peroxidase activity improves symptoms in models of the neurodegenerative disorder

Leicester geneticists have discovered a potential defence against Huntington's disease – a fatal neurodegenerative disorder which currently has no cure.

The team of University of Leicester researchers identified that glutathione peroxidase activity – a key antioxidant in cells – protects against symptoms of the disease in model organisms.

They hope that the enzyme activity – whose protective ability was initially observed in model organisms such as yeast - can be further developed and eventually used to treat people with the genetically-inherited disease.

The disease affects around 12 people per 100,000.

Their paper, Glutathione peroxidase activity is neuroprotective in models of Huntington's disease, was published in Nature Genetics on 25 August.

A team of experts from the University's Department of Genetics carried out research for more than six years to identify new potential drug targets for the disease.

They used model systems, such as baker's yeast, fruit flies, and cultured mammalian cells to help uncover potential mechanisms underlying disease at the cellular level.

They initially screened a genome-wide collection of yeast genes and found several candidates which protected against Huntington's related symptoms in yeast. They then validated their findings in fruit flies and mammalian cells.

They found that glutathione peroxidase activity is robustly protective in these models of Huntington's disease.

Importantly, there are drug-like compounds available that mimic this activity that have already been tested in human clinical trials for other disorders – which potentially means the approach could be used to treat people with the disease.

The team now aim to further validate the observations regarding glutathione peroxidase activity, in order to understand whether this could have therapeutic relevance for Huntington's.

In addition, they have identified many additional genes that are protective - and aim to further explore these to see if there are any additional therapeutic possibilities suggested by their research.

Dr Flaviano Giorgini, Reader in Neurogenetics of the University's Department of Genetics and senior author of the paper, said: "We are taking advantage of genetic approaches in simple model organisms in order to better understand Huntington's disease, with the aim of uncovering novel ways to treat this devastating disorder.

"It appears that glutathione peroxidase activity is a robustly protective antioxidant approach which may have relevance for Huntington's disease."

Dr Robert Mason, Research Associate in the Department of Genetics, and first author of the study, said: "In addition to glutathione peroxidase, this study has identified many genes that improve Huntington's 'symptoms' in yeast. These genes provide valuable information on the underlying mechanisms leading to Huntington's, and further study will likely uncover additional approaches that could be beneficial in treating this terrible disease."

Dr Giorgini stated: "We are excited by the work because it uncovers a potential new route for therapeutics in Huntington's disease. I am also proud that all of this work has been conducted at the Department of Genetics at the University of Leicester."

The study was performed in collaboration with Prof Charalambos Kyriacou, also of the Department of Genetics at Leicester. Massimiliano Casu, Nicola Butler, Dr Carlo Breda, Dr Susanna Campesan, Dr Jannine Clapp, Dr Edward Green and Devyani Dhulkhed also contributed to the research study.

The research was primarily funded by CHDI Foundation and the Huntington's Disease Association.

Dr. Flaviano Giorgini | EurekAlert!
Further information:
http://www.le.ac.uk

More articles from Life Sciences:

nachricht What the world's tiniest 'monster truck' reveals
23.08.2017 | American Chemical Society

nachricht Treating arthritis with algae
23.08.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

What the world's tiniest 'monster truck' reveals

23.08.2017 | Life Sciences

Treating arthritis with algae

23.08.2017 | Life Sciences

Witnessing turbulent motion in the atmosphere of a distant star

23.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>